InvestorsHub Logo
Followers 10
Posts 354
Boards Moderated 0
Alias Born 07/03/2013

Re: DewDiligence post# 23521

Sunday, 02/07/2021 7:51:46 PM

Sunday, February 07, 2021 7:51:46 PM

Post# of 29349
All things considered PCVX did alright valuation wise. Still pre-clinical and valued at 1.2 billion. If PCVX can prove out VAX-24 safety and efficacy and quickly follow up with VAX-30+, PCVX may have a better strategic position. Thanks for the PCVX discussion.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.